Trial Profile
A Multiple-Dose, Open-Label Study to Evaluate the Pharmacokinetics of MNTX in Healthy Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation
- Focus Pharmacokinetics
- Sponsors Progenics Pharmaceuticals; Salix Pharmaceuticals
- 10 Jun 2011 New trial record